Please find attached Annual Secretarial Compliance Report for the FY ended 31st March, 2025
MEDICO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Medico Remedies Ltd has submitted its Annual Secretarial Compliance Report for the financial year ended 31st March 2025, as required under Regulation 24A of SEBI LODR Regulations. The report, issued by Practicing Company Secretary Haresh Sanghvi, confirms that the company has fully complied with all applicable SEBI regulations, circulars, and guidelines during the review period. There were no deviations, no fines, and no actions taken by SEBI or stock exchanges against the company, its promoters, or directors. The company has no subsidiaries, no related party transactions without prior audit committee approval, and no resignation of statutory auditors during the year.
This is a routine compliance filing with a clean report — no penalties or regulatory actions were flagged, which is mildly positive for corporate governance perception but unlikely to materially affect the stock price.